The story has been corrected to say that the Nasdaq Biotechnology Index rose 7 percent in February, not 10 percent. We apologize for for the mistake. 

NEW YORK (360Dx) — Foundation Medicine, Invitae, Accelerate Diagnostics, and Myriad Genetics each saw their share prices jump more than 20 percent in February to pace the gainers in the 360Dx Index last month.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.